Quest Diagnostics
DGX
#1080
Rank
โ‚น1.852 T
Marketcap
โ‚น16,565
Share price
0.86%
Change (1 day)
23.79%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Number of shares outstanding for Quest Diagnostics (DGX)

Number of shares outstanding as of December 2025 : 112,000,000

According to Quest Diagnostics 's latest financial reports and stock price the company's current number of shares outstanding is 112,000,000. At the end of 2025 the company had 112,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Quest Diagnostics from 2005 to 2025

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20250.11 B0.9%
20240.11 B-0.89%
20230.11 B-0.88%
20220.11 B-7.38%
20210.12 B-9.63%
20200.13 B0.75%
20190.13 B-1.47%
20180.13 B0%
20170.13 B-1.45%
20160.13 B-3.5%
20150.14 B-1.38%
20140.14 B-0.68%
20130.14 B-8%
20120.15 B0.57%
20110.15 B-8.89%
20100.17 B-6.43%
20090.18 B-5.06%
20080.19 B0.82%
20070.19 B-1.92%
20060.19 B-2.72%
20050.20 B

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
LabCorp
LH
83,100,000-25.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
5,894,000-94.74%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
128,415,000 14.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
52,403,000-53.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
62,908,800-43.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
216,871,000 93.63%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands